This announcement is a separate document:
国金证券股份有限公司关于上海谊众药业股份有限公司2024年半年度持续督导跟踪报告
Sinolink Securities Co., Ltd. continuous supervision and tracking report on Shanghai Yizhong Pharmaceutical Co., Ltd. in the first half of 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.